For the year ending 2025-12-31, MET-PE has $745,166M in assets. $716,245M in debts. $22,032M in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Fixed maturity securities available-for-sale, at estimated fair value (net of allowance for credit loss of 249 and 160, respectively) and amortized cost 337,201 and 307,421, respectively | 315,931 | 281,043 | 281,412 | 276,780 |
| Equity securities, at estimated fair value | 858 | 712 | 757 | 1,684 |
| Contractholder-directed equity securities and fair value option securities, at estimated fair value (includes 1,751 and 0, respectively, relating to variable interest entities) | 13,959 | 10,672 | 10,331 | 9,668 |
| Mortgage loans (net of allowance for credit loss of 1,193 and 800, respectively includes 35 and 0, respectively, of mortgage loans held-for-sale) | 84,593 | 89,012 | 92,506 | 83,763 |
| Policy loans | 8,547 | 8,545 | 8,788 | 8,874 |
| Real estate and real estate joint ventures (includes 378 and 378, respectively, under the fair value option 132 and 65, respectively, of real estate held-for-sale 302 and 183, respectively, relating to variable interest entities) | 13,440 | 13,342 | 13,332 | 13,137 |
| Other limited partnership interests | 14,917 | 14,378 | 14,764 | 14,414 |
| Short-term investments, principally at estimated fair value | 3,601 | 5,156 | 6,045 | 4,935 |
| Other invested assets (includes 1,698 and 1,851, respectively, of leveraged and direct financing leases 560 and 424, respectively, relating to variable interest entities) | 16,332 | 18,504 | 18,202 | 20,038 |
| Total investments | 472,178 | 441,364 | 446,137 | 433,293 |
| Cash and cash equivalents, principally at estimated fair value (includes 96 and 0, respectively, relating to variable interest entities) | 22,032 | 20,068 | 20,639 | 20,195 |
| Accrued investment income | 3,719 | 3,489 | 3,589 | 3,446 |
| Premiums, reinsurance and other receivables (includes 0 and 47, respectively, relating to variable interest entities) | 49,059 | 29,761 | 28,971 | 17,461 |
| Market risk benefits, at estimated fair value | 458 | 372 | 286 | - |
| Deferred policy acquisition costs and value of business acquired | 21,107 | 19,627 | 20,151 | 22,983 |
| Current income tax recoverable | 660 | 295 | 190 | 42 |
| Deferred income tax asset | 2,585 | 2,994 | 2,612 | 2,830 |
| Goodwill | 9,613 | 8,901 | 9,236 | 9,297 |
| Assets held-for-sale | - | - | - | 0 |
| Other assets | 11,822 | 11,082 | 11,139 | 11,026 |
| Separate account assets | 151,933 | 139,504 | 144,634 | 146,038 |
| Total assets | 745,166 | 677,457 | 687,584 | 666,611 |
| Future policy benefits | 208,855 | 193,646 | 196,406 | 204,228 |
| Policyholder account balances | 236,857 | 221,445 | 219,269 | 203,082 |
| Market risk benefits, at estimated fair value | 2,406 | 2,581 | 3,179 | - |
| Other policy-related balances | 20,070 | 18,899 | 19,736 | 19,651 |
| Policyholder dividends payable | 356 | 385 | 386 | 387 |
| Policyholder dividend obligation | - | - | - | 0 |
| Payables for collateral under securities loaned and other transactions | 17,115 | 17,128 | 17,524 | 20,937 |
| Short-term debt (includes 117 and 133, respectively, relating to variable interest entities) | 355 | 465 | 119 | 175 |
| Long-term debt (includes 28 and 0, respectively, relating to variable interest entities) | 14,467 | 15,086 | 15,548 | 14,647 |
| Collateral financing arrangement | 352 | 476 | 637 | 716 |
| Subordinated debt securities | 4,155 | - | - | - |
| Junior subordinated debt securities | - | 3,164 | 3,161 | 3,158 |
| Notes issued by collateralized financing entities | 1,206 | - | - | - |
| Deferred income tax liability | 536 | 132 | 927 | 325 |
| Liabilities held-for-sale | - | - | - | 0 |
| Other liabilities (includes 167 and 0, respectively, relating to variable interest entities) | 57,582 | 36,843 | 35,805 | 25,980 |
| Separate account liabilities | 151,933 | 139,504 | 144,634 | 146,038 |
| Total liabilities | 716,245 | 649,754 | 657,331 | 639,324 |
| Redeemable noncontrolling interests | 241 | - | - | - |
| Common stock, par value 0.01 per share 3,000,000,000 shares authorized 1,195,587,190 and 1,194,168,628 shares issued, respectively 655,333,773 and 689,211,065 shares outstanding,respectively | 12 | 12 | 12 | 12 |
| Additional paid-in capital | 32,858 | 33,791 | 33,690 | 33,616 |
| Retained earnings | 44,290 | 42,626 | 40,146 | 41,953 |
| Treasury stock, at cost 540,253,417 and 504,957,563 shares, respectively | 30,678 | 27,798 | 24,591 | 21,458 |
| Accumulated other comprehensive income (loss) | -18,084 | -21,186 | -19,242 | -27,083 |
| Total metlife, inc.s stockholders equity | 28,398 | 27,445 | 30,015 | 27,040 |
| Noncontrolling interests | 282 | 258 | 238 | 247 |
| Total equity | 28,680 | 27,703 | 30,253 | 27,287 |
| Total liabilities, mezzanine equity and equity | 745,166 | 677,457 | 687,584 | 666,611 |
METLIFE INC (MET-PE)
METLIFE INC (MET-PE)